Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PLJT-004
- Development stage
- Preclinical
- Lead developer
- Panlong Pharmaceutical
01
Overview
PLJT-004 is an **improved traditional Chinese medicine** candidate being developed by Panlong Pharma for **orthopedic pain**. It is reported to be in preclinical research. Public disclosures do not specify its herbal composition, molecular targets, pharmacologic mechanism, dosage form, or route of administration.
Beyond the preview
Go deeper on PLJT-004.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PLJT-004.